Portfolio company BitBio recently announced a partnership with Automata, a leading life science lab robotics and automation company to automate a key aspect of the manufacturing process of their iPSC (induced pluripotent stem cell) products.  The automation will help meet demand of BitBio’s cellular reprogramming technology (opti-ox) by quadrupling capacity & producing consistent human cells for research and drug discovery.